Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Nivolumab in Melanoma: NCT07221734 Clinical Landscape Report 2026
28 September 2026
NCT07221734 clinical landscape for Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ipilimumab in Mucosal Melanoma: NCT07230613 Clinical Landscape Report 2026
28 September 2026
NCT07230613 clinical landscape for Mucosal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mirdametinib in Metastatic melanoma: NCT07237100 Clinical Landscape Report 2026
28 September 2026
NCT07237100 clinical landscape for Metastatic melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pembrolizumab in Pancreatic Ductal Adenocarcinoma: NCT07227168 Clinical Landscape Report 2026
28 September 2026
NCT07227168 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
BI-3810944 in Melanoma: NCT07224425 Clinical Landscape Report 2026
28 September 2026
NCT07224425 clinical landscape for Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
NTR-1011 in Rheumatoid Arthritis: NCT07237659 Clinical Landscape Report 2026
28 September 2026
NCT07237659 clinical landscape for Rheumatoid Arthritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apatinib Mesylate in Recurrent Mucosal Melanoma: NCT07236528 Clinical Landscape Report 2026
28 September 2026
NCT07236528 clinical landscape for Recurrent Mucosal Melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
YTS-109 in Myositis: NCT07236762 Clinical Landscape Report 2026
28 September 2026
NCT07236762 clinical landscape for Myositis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Secukinumab in Metastatic melanoma: NCT07237594 Clinical Landscape Report 2026
28 September 2026
NCT07237594 clinical landscape for Metastatic melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
VENT-03 in Lupus Erythematosus, Cutaneous: NCT07260877 Clinical Landscape Report 2026
28 September 2026
NCT07260877 clinical landscape for Lupus Erythematosus, Cutaneous: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Entinostat in Bladder Cancer: NCT07261592 Clinical Landscape Report 2026
28 September 2026
NCT07261592 clinical landscape for Bladder Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
KN-3601 in Granulomatosis With Polyangiitis: NCT07246096 Clinical Landscape Report 2026
28 September 2026
NCT07246096 clinical landscape for Granulomatosis With Polyangiitis: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…